Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 7/25/2011 11:36:06 AM : Outperform Start Price: $58.67 ALXN Score: +57.99

ibd

Featured Broker Partners


Advertisement